ID: ALA4087587

Max Phase: Preclinical

Molecular Formula: C14H12N2O2

Molecular Weight: 240.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1noc2cc(-c3ccccc3)n(C)c(=O)c12

Standard InChI:  InChI=1S/C14H12N2O2/c1-9-13-12(18-15-9)8-11(16(2)14(13)17)10-6-4-3-5-7-10/h3-8H,1-2H3

Standard InChI Key:  UHJPAJUXJVHRKX-UHFFFAOYSA-N

Associated Targets(Human)

dCTP pyrophosphatase 1 562 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 240.26Molecular Weight (Monoisotopic): 240.0899AlogP: 2.50#Rotatable Bonds: 1
Polar Surface Area: 48.03Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.26CX LogD: 1.26
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.66Np Likeness Score: -1.00

References

1. Llona-Minguez S, Häggblad M, Martens U, Johansson L, Sigmundsson K, Lundbäck T, Loseva O, Jemth AS, Lundgren B, Jensen AJ, Scobie M, Helleday T..  (2017)  Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems.,  27  (15): [PMID:28655422] [10.1016/j.bmcl.2017.06.039]

Source